Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Relapse After Successful Electroconvulsive Therapy for Depression. A Randomized Controlled Trial on Lithium as add-on to Personalized Maintenance ECT.

NCT06751875 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

NCT NCT06751875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06751875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Relapse After Successful Electroconvulsive Therapy for Depression. A Randomized Controlled Trial on Lithium as add-on to Personalized Maintenance ECT.
Lead sponsor
Universiteit Antwerpen
Phase
Not applicable
Overall status
Completed
Start date
July 26, 2019
Completion date
December 31, 2024
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd)